Logo image of DAN

DANA INC (DAN) Stock Fundamental Analysis

USA - NYSE:DAN - US2358252052 - Common Stock

18.935 USD
-0.6 (-3.05%)
Last: 10/7/2025, 11:02:23 AM
Fundamental Rating

2

DAN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 81 industry peers in the Automobile Components industry. DAN may be in some trouble as it scores bad on both profitability and health. DAN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

DAN had positive earnings in the past year.
DAN had a positive operating cash flow in the past year.
In multiple years DAN reported negative net income over the last 5 years.
DAN had a positive operating cash flow in each of the past 5 years.
DAN Yearly Net Income VS EBIT VS OCF VS FCFDAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

DAN has a worse Return On Assets (-0.29%) than 76.54% of its industry peers.
DAN has a worse Return On Equity (-1.99%) than 72.84% of its industry peers.
DAN has a worse Return On Invested Capital (2.47%) than 79.01% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DAN is below the industry average of 8.51%.
Industry RankSector Rank
ROA -0.29%
ROE -1.99%
ROIC 2.47%
ROA(3y)-1.18%
ROA(5y)-0.27%
ROE(3y)-5.82%
ROE(5y)-1.8%
ROIC(3y)5.11%
ROIC(5y)4.79%
DAN Yearly ROA, ROE, ROICDAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

With a Operating Margin value of 2.05%, DAN is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of DAN has declined.
With a Gross Margin value of 7.42%, DAN is not doing good in the industry: 90.12% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of DAN has declined.
Industry RankSector Rank
OM 2.05%
PM (TTM) N/A
GM 7.42%
OM growth 3Y-6.44%
OM growth 5Y-14.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-8.28%
DAN Yearly Profit, Operating, Gross MarginsDAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1

2. Health

2.1 Basic Checks

DAN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DAN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DAN has more shares outstanding
The debt/assets ratio for DAN is higher compared to a year ago.
DAN Yearly Shares OutstandingDAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
DAN Yearly Total Debt VS Total AssetsDAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that DAN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.54, DAN is doing worse than 81.48% of the companies in the same industry.
DAN has a debt to FCF ratio of 107.59. This is a negative value and a sign of low solvency as DAN would need 107.59 years to pay back of all of its debts.
DAN's Debt to FCF ratio of 107.59 is on the low side compared to the rest of the industry. DAN is outperformed by 77.78% of its industry peers.
DAN has a Debt/Equity ratio of 2.57. This is a high value indicating a heavy dependency on external financing.
DAN's Debt to Equity ratio of 2.57 is on the low side compared to the rest of the industry. DAN is outperformed by 90.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF 107.59
Altman-Z 1.54
ROIC/WACC0.27
WACC9.12%
DAN Yearly LT Debt VS Equity VS FCFDAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

DAN has a Current Ratio of 1.36. This is a normal value and indicates that DAN is financially healthy and should not expect problems in meeting its short term obligations.
DAN has a worse Current ratio (1.36) than 86.42% of its industry peers.
DAN has a Quick Ratio of 1.00. This is a normal value and indicates that DAN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.00, DAN is doing worse than 81.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1
DAN Yearly Current Assets VS Current LiabilitesDAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.14% over the past year.
DAN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.71% yearly.
The Revenue for DAN has decreased by -19.83% in the past year. This is quite bad
DAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.59% yearly.
EPS 1Y (TTM)7.14%
EPS 3Y-18.46%
EPS 5Y-21.71%
EPS Q2Q%63.19%
Revenue 1Y (TTM)-19.83%
Revenue growth 3Y4.76%
Revenue growth 5Y3.59%
Sales Q2Q%-29.33%

3.2 Future

Based on estimates for the next years, DAN will show a very strong growth in Earnings Per Share. The EPS will grow by 23.16% on average per year.
The Revenue is expected to decrease by -4.91% on average over the next years.
EPS Next Y42.97%
EPS Next 2Y46.34%
EPS Next 3Y43.5%
EPS Next 5Y23.16%
Revenue Next Year-15.45%
Revenue Next 2Y-11.79%
Revenue Next 3Y-8.58%
Revenue Next 5Y-4.91%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DAN Yearly Revenue VS EstimatesDAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
DAN Yearly EPS VS EstimatesDAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.04, the valuation of DAN can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of DAN indicates a slightly more expensive valuation: DAN is more expensive than 60.49% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of DAN to the average of the S&P500 Index (27.90), we can say DAN is valued slightly cheaper.
The Price/Forward Earnings ratio is 9.82, which indicates a very decent valuation of DAN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DAN indicates a somewhat cheap valuation: DAN is cheaper than 61.73% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of DAN to the average of the S&P500 Index (23.36), we can say DAN is valued rather cheaply.
Industry RankSector Rank
PE 21.04
Fwd PE 9.82
DAN Price Earnings VS Forward Price EarningsDAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DAN is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, DAN is valued a bit more expensive than the industry average as 75.31% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 85.63
EV/EBITDA 8.39
DAN Per share dataDAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

DAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DAN's earnings are expected to grow with 43.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y46.34%
EPS Next 3Y43.5%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.00%, DAN has a reasonable but not impressive dividend return.
DAN's Dividend Yield is comparable with the industry average which is at 3.93.
DAN's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2%

5.2 History

The dividend of DAN decreases each year by -0.02%.
DAN has been paying a dividend for at least 10 years, so it has a reliable track record.
DAN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-0.02%
Div Incr Years0
Div Non Decr Years4
DAN Yearly Dividends per shareDAN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

The earnings of DAN are negative and hence is the payout ratio. DAN will probably not be able to sustain this dividend level.
DP-241.67%
EPS Next 2Y46.34%
EPS Next 3Y43.5%
DAN Yearly Income VS Free CF VS DividendDAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

DANA INC

NYSE:DAN (10/7/2025, 11:02:23 AM)

18.935

-0.6 (-3.05%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)10-23 2025-10-23/amc
Inst Owners103.41%
Inst Owner Change0%
Ins Owners0.5%
Ins Owner Change-0.02%
Market Cap2.48B
Analysts75.71
Price Target24.5 (29.39%)
Short Float %2.81%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield 2%
Yearly Dividend0.4
Dividend Growth(5Y)-0.02%
DP-241.67%
Div Incr Years0
Div Non Decr Years4
Ex-Date08-08 2025-08-08 (0.1)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-11.52%
Min Revenue beat(2)-24.38%
Max Revenue beat(2)1.34%
Revenue beat(4)1
Avg Revenue beat(4)-7.24%
Min Revenue beat(4)-24.38%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-4.59%
Revenue beat(12)5
Avg Revenue beat(12)-2.82%
Revenue beat(16)9
Avg Revenue beat(16)-0.67%
PT rev (1m)1.48%
PT rev (3m)10.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.07%
EPS NY rev (1m)-10.28%
EPS NY rev (3m)-6.42%
Revenue NQ rev (1m)-5.59%
Revenue NQ rev (3m)-17.11%
Revenue NY rev (1m)-7.9%
Revenue NY rev (3m)-10.1%
Valuation
Industry RankSector Rank
PE 21.04
Fwd PE 9.82
P/S 0.29
P/FCF 85.63
P/OCF 7.48
P/B 2.06
P/tB 2.21
EV/EBITDA 8.39
EPS(TTM)0.9
EY4.75%
EPS(NY)1.93
Fwd EY10.18%
FCF(TTM)0.22
FCFY1.17%
OCF(TTM)2.53
OCFY13.37%
SpS65.02
BVpS9.18
TBVpS8.58
PEG (NY)0.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.29%
ROE -1.99%
ROCE 3.45%
ROIC 2.47%
ROICexc 2.7%
ROICexgc 2.75%
OM 2.05%
PM (TTM) N/A
GM 7.42%
FCFM 0.34%
ROA(3y)-1.18%
ROA(5y)-0.27%
ROE(3y)-5.82%
ROE(5y)-1.8%
ROIC(3y)5.11%
ROIC(5y)4.79%
ROICexc(3y)5.65%
ROICexc(5y)5.25%
ROICexgc(3y)6.23%
ROICexgc(5y)5.9%
ROCE(3y)6.51%
ROCE(5y)6.09%
ROICexcg growth 3Y1.47%
ROICexcg growth 5Y-10.58%
ROICexc growth 3Y3.3%
ROICexc growth 5Y-9.33%
OM growth 3Y-6.44%
OM growth 5Y-14.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-8.28%
F-Score2
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF 107.59
Debt/EBITDA 5.57
Cap/Depr 79.53%
Cap/Sales 3.55%
Interest Coverage 250
Cash Conversion 59.71%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1
Altman-Z 1.54
F-Score2
WACC9.12%
ROIC/WACC0.27
Cap/Depr(3y)107.96%
Cap/Depr(5y)101.61%
Cap/Sales(3y)4.26%
Cap/Sales(5y)4.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.14%
EPS 3Y-18.46%
EPS 5Y-21.71%
EPS Q2Q%63.19%
EPS Next Y42.97%
EPS Next 2Y46.34%
EPS Next 3Y43.5%
EPS Next 5Y23.16%
Revenue 1Y (TTM)-19.83%
Revenue growth 3Y4.76%
Revenue growth 5Y3.59%
Sales Q2Q%-29.33%
Revenue Next Year-15.45%
Revenue Next 2Y-11.79%
Revenue Next 3Y-8.58%
Revenue Next 5Y-4.91%
EBIT growth 1Y-52.57%
EBIT growth 3Y-1.99%
EBIT growth 5Y-10.97%
EBIT Next Year69.94%
EBIT Next 3Y22.39%
EBIT Next 5Y16.23%
FCF growth 1Y-76.42%
FCF growth 3YN/A
FCF growth 5Y-19.8%
OCF growth 1Y-44.57%
OCF growth 3Y41.75%
OCF growth 5Y-6.71%